Trends in Pharmacological Sciences
OpinionRole of 5-HT2C receptors in the control of central dopamine function
Section snippets
Distribution of 5-HT receptor subtypes in the basal ganglia
Several 5-HT receptor subtypes have been shown to be present in the basal ganglia. A high density of 5-HT1B receptors has been found in the SN, VTA, globus pallidus and entopeduncular nucleus 4, 5, although 5-HT1A binding sites and mRNA encoding the 5-HT1A receptor are barely detectable in these nuclei 5. High to moderate levels of 5-HT2A and 5-HT2C receptor binding sites and the corresponding mRNA are present in several forebrain areas including the basal ganglia and the limbic system. Thus,
5-HT and the electrical activity of DA neurons in the SNc and VTA
Acute administration of the selective 5-HT reuptake inhibitor (SSRI) fluoxetine causes a dose-dependent inhibition of the firing rate of VTA DA-containing neurons, but it does not affect the activity of DA-containing cells in the SNc (Ref. 12). A similar effect, although less pronounced, has been observed following administration of the SSRI citalopram 12. Furthermore, mesulergine, a nonselective 5-HT2C receptor antagonist 13, or the destruction of 5-HT-containing neurons by the neurotoxin
Effects of 5-HT2C receptor agonists and antagonists on DA-mediated function
A series of studies carried out in our laboratory has clearly shown that 5-HT2C receptors play a prominent role in the control of mesocorticolimbic DA-mediated function. Initially, it was found that the firing rate of DA-containing neurons in the VTA was reduced by mCPP and trifluoromethylphenylpiperazine (TFMPP) (a mixed 5-HT2A/2B/2C receptor agonist) 14, whereas these neurons were stimulated by mesulergine 10. Although, on the basis of these findings, it was suggested that 5-HT could exert an
Concluding remarks
In view of the hypothesis that disinhibition of the mesolimbic DA system underlies the mechanism of action of several antidepressant drugs 28, the disinhibitory effect of SB206553 and SB242084 on the mesolimbic DA system might open new possibilities for the employment of 5-HT2C receptor antagonists as antidepressants. This hypothesis is consistent with the suggestion that 5-HT2C receptor antagonists might exert antidepressant activity 29. In this respect, it is interesting to note that several
Acknowledgements
We would like to thank Daniela Sciarra and Sara Di Pierdomenico for their helpful assistance in the preparation of the manuscript. This work was supported by the CNR, Target Project on Biotechnology ctr. N. 990012549, the EC Biomed program-PL 963566 and the Associazione Italiana per la Ricerca sul Cancro (AIRC).
References (34)
Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons
Brain Res.
(1987)Quantitative and morphometric data indicate precise cellular interactions between serotonin and postsynaptic targets in rat substantia nigra
Neuroscience
(1997)- et al.
Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors
Brain Res.
(1985) - et al.
A review of central 5-HT receptors and their function
Neuropharmacology
(1999) Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors
Mol. Brain Res.
(1994)Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists
Eur. J. Pharmacol.
(1994)- et al.
Molecular biology of 5-HT receptors
Neuropharmacology
(1994) Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin2C receptors
Brain Res.
(2000)Selective blockade of serotonin2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study
Neuroscience
(1999)Selective bockade of serotonin2C/2B receptors enhances dopamine release in the rat nucleus accumbens
Neuropharmacology
(1998)
SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist
Neuropharmacology
SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system
Neuropharmacology
Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo
Neuropharmacology
Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT2C/2B receptor antagonists: neurochemical and behavioural studies
Neuropharmacology
m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors
Neuroscience
5-HT2 receptor subtypes: a family reunited?
Trends Pharmacol. Sci.
Brain 5-HT1C receptors and antidepressants
Progr. Neuropsychopharmacol. Biol. Psychiatry
Cited by (212)
Interactions between lorcaserin and opioids: Ventilation and food-versus-drug choice
2024, Pharmacology Biochemistry and BehaviorMicroRNA schizophrenia: Etiology, biomarkers and therapeutic targets
2023, Neuroscience and Biobehavioral ReviewsThe Neurodegenerative Elderly Syndrome (NES) hypothesis: Alzheimer and Parkinson are two faces of the same disease
2022, IBRO Neuroscience ReportsSerotonin/dopamine interaction: Electrophysiological and neurochemical evidence
2021, Progress in Brain Research